ArticleMolecular biology reports2026
Dose-dependent effect of curcumin nanomicelle on autophagy signaling in testis; a study on normal Wistar rats.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCurcumin nanomicelles (CNM), a bioavailable formulation of curcumin, have demonstrated therapeutic potential due to their antioxidant and anti-inflammatory properties. However, increasing evidence indicates that dose, exposure duration, and physiological context may influence their biological effects in reproductive tissues. This study investigated the dose-dependent impact of CNM on testicular histology, carbohydrate and lipid storage patterns, apoptosis, testosterone status, and autophagy-related gene expression in healthy rats. METHODS AND
resultsAdult male rats were orally administered CNM at doses of 7.5, 15, or 30 mg/kg for 48 days. Histomorphometric analyses revealed significant reductions in the number of Leydig and Sertoli cells, germinal epithelium height, seminiferous tubule diameter, and the percentage of tubules with positive spermatogenic indices (TDI and SPI) in the 15 and 30 mg/kg groups. Histochemical staining showed a dose-dependent reduction in PAS-positive carbohydrate-associated reactivity and an increase in SBB-positive lipid-associated staining in germ and somatic cells. These findings indicate altered carbohydrate and lipid storage patterns but do not directly measure metabolic flux or pathway activity. CNM also reduced serum testosterone levels and ANS-positive Leydig cell fluorescence, an indirect histochemical indicator of lipid-associated steroidogenic potential, while increasing TUNEL-positive apoptotic cells, particularly at higher doses. In addition, CNM administration upregulated the mRNA expression of autophagy-related genes (Atg7, Beclin-1, p62, and LC3-I) in whole testicular tissue. These transcript-level findings suggest modulation of autophagy-associated signaling but do not by themselves establish autophagic flux or cell-specific autophagic activity.
conclusionsThese findings suggest that CNM alters testicular structural organization, carbohydrate and lipid storage patterns, testosterone status, apoptosis, and autophagy-related gene expression in a dose-dependent manner. The conclusions have been revised to reflect the measured endpoints and to avoid unsupported claims regarding steroidogenic activity, metabolic pathway flux, autophagic activity, or cell-specific autophagy mechanisms.
Indexed as
Identifiers
42424014What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.